Advanced search
Publication Cover
Renal Failure Volume 43, 2021 - Issue 1
Submit an article Journal homepage
1,670
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease

Xiaoxia YangDepartment of Nephrology, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaView further author information
,
Feng MaDepartment of Nephrology, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaView further author information
,
Ming BaiDepartment of Nephrology, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaView further author information
,
Yan WangDepartment of Nephrology, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaView further author information
,
Qing JiaDepartment of Nephrology, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaView further author information
,
Ruijuan DongDepartment of Nephrology, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaView further author information
,
Chunmei LiuDepartment of Nephrology, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaView further author information
&
Shiren SunDepartment of Nephrology, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4647-4442View further author information
ORCID Icon show all
Pages 1180-1187 | Received 07 Dec 2020, Accepted 07 Jul 2021, Published online: 10 Aug 2021

References

  • Moran SM, Cattran DC. Recent advances in risk prediction, therapeutics and pathogenesis of IgA nephropathy. Minerva Med. 2019;110(5):439–449.
  • Berthoux F, Mohey H, Laurent B, et al. Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol. 2011;22(4):752–761.
  • Barbour S, Reich H. An update on predicting renal progression in IgA nephropathy. Curr Opin Nephrol Hypertens. 2018;27(3):214–220.
  • Reid S, Cawthon PM, Craig JC, et al. Non-immunosuppressive treatment for IgA nephropathy. Cochrane Database Syst Rev. 2011;(3):CD003962.
  • Coppo R, Feehally J, Glassock RJ. IgA nephropathy at two score and one. Kidney Int. 2010;77(3):181–186.
  • Hou FF, Zhang X, Zhang GH, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med. 2006;354(2):131–140.
  • Roberts IS. Pathology of IgA nephropathy. Nat Rev Nephrol. 2014;10(8):445–454.
  • Hou JH, Le WB, Chen N, et al. Mycophenolate mofetil combined with prednisone versus full-dose prednisone in IgA nephropathy with active proliferative lesions: a randomized controlled trial. Am J Kidney Dis. 2017;69(6):788–795.
  • Coppo R. Corticosteroids in IgA nephropathy: lessons from recent studies. J Am Soc Nephrol. 2017;28(1):25–33.
  • Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol. 2002;13(1):142–148.
  • Zhang Y, Luo J, Hu B, et al. Efficacy and safety of tacrolimus combined with glucocorticoid treatment for IgA nephropathy: a meta-analysis. J Int Med Res. 2018;46(8):3236–3250.
  • Tang SC, Tang AW, Wong SS, et al. Long-term study of mycophenolate mofetil treatment in IgA nephropathy. Kidney Int. 2010;77(6):543–549.
  • Floege J, Feehally J. Treatment of IgA nephropathy and Henoch-Schönlein nephritis. Nat Rev Nephrol. 2013;9(6):320–327.
  • Lv J, Xu D, Perkovic V, et al. Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol. 2012;23(6):1108–1116.
  • Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15(1):157–163.
  • Rauen T, Eitner F, Fitzner C, et al. Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med. 2015;373(23):2225–2236.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
  • Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–545.
  • Tesar V, Troyanov S, Bellur S, et al. Corticosteroids in IgA nephropathy: a retrospective analysis from the VALIGA study. J Am Soc Nephrol. 2015;26(9):2248–2258.
  • Barbour SJ, Cattran DC, Kim SJ, et al. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Kidney Int. 2013;84(5):1017–1024.
  • Fellström BC, Barratt J, Cook H, et al. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet. 2017;389(10084):2117–2127.
  • Ma F, Yang X, Zhou M, et al. Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide. J Nephrol. 2020;33(6):1241–1250.
  • Lv J, Zhang H, Wong MG, et al. Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA. 2017;318(5):432–442.
  • Singh JA, Hossain A, Kotb A, et al. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis. BMC Med. 2016;14(1):137.
  • Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008;3(5):1487–1493.
  • Wang L, Ren D, Huang T, et al. The effectiveness and safety of full-dose versus half-dose corticosteroid plus renin-angiotensin system blockers for IgA nephropathy. Ther Adv Chronic Dis. 2019;10:2040622319887875.
  • Shin JH, Lee JE, Park JH, et al. The effects of cytotoxic therapy in progressive IgA nephropathy. Ann Med. 2016;48(3):171–181.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.